Ajanta Pharma promoter releases pledge on 98,185 shares

Pledge releasedOwnership Changes View source PDF Explain this filing

AJANTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.7%Reaction day

₹3540.00

prior close

₹3543.10

announcement price

In-mkt

timing

Nifty Midcap 150market-1.6%+1.0% vs market

Pharmaceuticals peers, median of 172sector-1.5%+0.8% vs sector

On the reaction day the stock moved 1.0 pts more than Nifty Midcap 150 and 0.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.4

10m

+0.1

15m

+0.2

30m

+0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.7-1.6+1.0-1.5+0.8

Next day

+0.1-2.6+2.7-1.0+1.1

+1.5-2.5+4.0-1.9+3.4

+1.3-3.5+4.8-2.5+3.8

-1.1-3.0+1.9-3.4+2.2

+0.6-2.0+2.6-2.4+3.0

-3.0-5.0+2.1-4.3+1.3

15d

-7.9-5.5-2.4-7.8-0.1

-2.1-6.1+4.0-6.6+4.5

—————

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Promoter Aayush Agrawal of Ajanta Pharma disclosed release of pledge on 98,185 equity shares (about 0.08% of total share capital) under SEBI SAST Regulations. The release was done in three tranches on Sep 21, 22, and 23, 2026, with Aditya Birla Capital Ltd as the lender. Reason cited is loan repayment. Post-release, the encumbered promoter holding has reduced, lowering the pledged share burden on the promoter group.

Likely market impact

Pledge release due to loan repayment reduces promoter encumbrance, generally viewed as a positive signal for the stock.